Clinical trial · Interventional
High Tea Consumption on Smoking Related Oxidative Stress
A Chemoprevention Trial to Study the Effects of High Tea Consumption on Smoking Related Oxidative Stress
NCT02719860CI-TRIAL-00021512completedPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The overall objective of this study is to determine the effect of high tea consumption on biological markers of oxidative stress that mediate lung cancer risk.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer Prevention | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Black tea | Dietary Supplement | — | UNRESOLVED |
| Green tea | Dietary Supplement | — | UNRESOLVED |
| Placebo tea | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- Green tea
- interventionNames
- Dietary Supplement: Green tea
- type
- EXPERIMENTAL
- label
- Black tea
- interventionNames
- Dietary Supplement: Black tea
- type
- PLACEBO_COMPARATOR
- label
- Placebo tea
- interventionNames
- Dietary Supplement: Placebo tea
Primary outcomes (2)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 40 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * FEV1 \< 85% and at least 25 pack-years of current or former smoking history. * No diagnosis of internal cancer within the last 5 years or no chemotherapy or radiation for an internal cancer within the last 5 years. * Meets the Southwest Oncology Group (SWOG) performance status criteria of 0-1. * Not be pregnant or intending to get pregnant during the study period (women participants). * Willing to drink 4 cups of tea (each cup will be brewed with 2 tea bags and 12 ounces of water) for 1-month run-in period and for the 6-month intervention period. * Willing to refrain from consuming other tea or tea products starting one month before the placebo run-in period and for the entire study period (a total of 8 months) * Willing to refrain from consuming more than one caffeinated product (coffee, soda..) starting one month before the placebo run-in period and for the entire study period (a total of 8 months). * Subjects cannot take mega-doses of vitamins during the trial. This is defined as more than 400 IU of vitamin E, 200 ug of selenium, or 1 gm of vitamin C per day, or more than the tolerable upper limits of any other supplement as defined in the Dietary Reference Intake panels developed by the Food and Nutrition Board under the Institute of Medicine. Such vitamin therapy must be discontinued at least 2 weeks prior to study entry. Exclusion Criteria: * Subjects immunosuppressed by virtue of medication or disease. * Serious concurrent illness that could interfere with study regimen. * Subjects with a history of invasive cancer within the past 5 years. * Subjects who are drinking more than 5 cups of non-herbal tea per week. * Subjects who cannot or are unwilling to consume caffeinated beverages. * Subjects unable to perform forced expiratory maneuver during spirometry testing. * More than one acute emphysema exacerbation within the last 6 month -period . * Subjects on oxygen. * Women with positive urinary pregnancy test.
References
Publications (0)
Data not yet available
No reference posted for this study.